Related / Contacts
Related / News
Press Releases • Feb 20, 2014 07:03 GMT
Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its results for the fourth quarter and full year 2013. Revenues for the year totalled SEK 2,177 M (1,923), an increase of 13 per cent. Revenues in the fourth quarter were 29 per cent higher compared to the previous year. All parts of the business contributed to the result with Kineret® and Partner Products delivering strong performance.
Related / Images & Videos
Related / Documents
Sobi had an eventful year in 2013 with strong operating performance and significant pipeline progress. Revenues in the quarter rose by 29 per cent and in the year by 13 per cent compared to the previous year. Our gross margin increased substantially, and we strengthened our company financially through both positive cash flow and improved operating profit.